| 71 |
Six-minute walk test: a useful tool for evaluating functional capacity in chronic hepatitis C |
2018 |
| 72 |
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update |
2017 |
| 73 |
Deregulation of miR-34a and Its Chaperon Hsp70 in Hepatitis C virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma Patients
|
2017 |
| 74 |
Latent tuberculosis infection among patients with erectile dysfunction |
2017 |
| 75 |
Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy |
2017 |
| 76 |
Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy |
2017 |
| 77 |
Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy |
2017 |
| 78 |
Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy |
2017 |
| 79 |
Noninvasive biomarkers as surrogate predictors of clinical
and endoscopic remission after infliximab induction in
patients with refractory ulcerative colitis |
2017 |
| 80 |
Noninvasive biomarkers as surrogate predictors of clinical
and endoscopic remission after infliximab induction in
patients with refractory ulcerative colitis |
2017 |